CD34 and acute lymphoblastic leukemia: To understand the regulatory underpinnings of their lineage ambiguity, we comprehensively profiled the epigenetic and transcriptional landscape of CIMP leukemias, as well as that of T-ALL, AML, and CD34+ cells from healthy donors (Fig. 1b).